scholarly article | Q13442814 |
P50 | author | Roger S. Blumenthal | Q106623018 |
John A Rumberger | Q114334443 | ||
Joel B Braunstein | Q116781734 | ||
Erin D. Michos | Q40222582 | ||
Matthew J Budoff | Q40403049 | ||
Khurram Nasir | Q75515424 | ||
Wendy S. Post | Q102265913 | ||
P433 | issue | 1 | |
P921 | main subject | atherosclerosis | Q12252367 |
P1104 | number of pages | 6 | |
P304 | page(s) | 201-206 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Atherosclerosis | Q4813570 |
P1476 | title | Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women | |
P478 | volume | 184 |
Q37670971 | 25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension--Is it worth the "hype"? |
Q39911933 | Association of coronary artery calcium and congestive heart failure in the general population: Results of the Heinz Nixdorf Recall study |
Q44813000 | Asymptomatic subjects with zero coronary calcium score: coronary CT angiographic features of plaques in event-prone patients |
Q39264114 | Breast arterial calcification association with coronary artery calcium scoring and implications for cardiovascular risk assessment in women. |
Q37604870 | Calcification in atherosclerosis |
Q37346122 | Cardiovascular disease in older women: a challenge in diagnosis and treatment |
Q53514044 | Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. |
Q35627037 | Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women |
Q38821831 | Chronic stress is associated with reduced circulating hematopoietic progenitor cell number: A maternal caregiving model |
Q34733233 | Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. |
Q43406786 | Common carotid intima-media thickness in cardiovascular risk stratification of older people: the Rotterdam Study |
Q38811609 | Coronary Artery Calcification |
Q89483665 | Coronary Artery Calcium Score: the "Mammogram" of the Heart? |
Q37063940 | Coronary artery calcium scores: current thinking and clinical applications |
Q33788911 | Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score |
Q34640666 | Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review |
Q53188679 | Demonstration of the Glagov phenomenon in vivo by CT coronary angiography in subjects with elevated Framingham risk. |
Q37949425 | Determining patient prognosis using computed tomography coronary angiography |
Q46868484 | Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study |
Q35317556 | Endothelial function in women of the Kronos Early Estrogen Prevention Study |
Q36812774 | Expert review on coronary calcium |
Q52655750 | Gender difference in the association between brachial-ankle pulse wave velocity and cardiovascular risk scores. |
Q36589435 | Genetic loci associated with nonobstructive coronary artery disease in Caucasian women |
Q34795273 | Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines |
Q33709966 | Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial |
Q37832982 | Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles |
Q52677849 | Imaging to Assess Ischemic Heart Disease in Women. |
Q34112745 | Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis |
Q30451489 | Improving Cardiovascular Risk Reduction for Primary Prevention—Utility of Lifetime Risk Assessment |
Q36960896 | Incident coronary artery calcium among postmenopausal women |
Q33596583 | Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis |
Q34779570 | Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in individuals classified as low-risk according to Framingham |
Q40186349 | Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults |
Q92327387 | Migraine without Aura and Subclinical Atherosclerosis in Young Females: Is Gut Microbiota to Blame? |
Q35816400 | Myocardial ischemia in women: lessons from the NHLBI WISE study |
Q37368214 | N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification |
Q36230465 | Parental Age of Onset of Cardiovascular Disease as a Predictor for Offspring Age of Onset of Cardiovascular Disease |
Q26991787 | Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines |
Q36431307 | Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis |
Q45106351 | Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiography |
Q37499363 | Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association |
Q52927853 | Relationship between Framingham risk score and subclinical atherosclerosis in carotid plaques: an in vivo study using multi-contrast MRI. |
Q64075156 | Segment-specific association of carotid-intima-media thickness with cardiovascular risk factors - findings from the STAAB cohort study |
Q39932654 | Sensitivity of digital thermal monitoring parameters to reactive hyperemia |
Q89689457 | Sex Differences in Coronary Artery Calcium and Long-term CV Mortality |
Q89794151 | Sexual Dimorphism of Coronary Artery Disease in a Low- and Intermediate-Risk Asymptomatic Population: Association with Coronary Vessel Wall Thickness at MRI in Women |
Q54427154 | Short and lifetime cardiovascular risk estimates: same wine, different bottles. Do we have the COURAGE to abandon risk scores? |
Q42370573 | Stable ischemic heart disease in women: current perspectives |
Q38392235 | Statins and aspirin: do they really work in women? |
Q84443305 | The Texas Heart Attack Prevention Bill mandating coverage for CAD screening tests |
Q39975769 | The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women |
Q36253311 | The association between plasma 25-hydroxyvitamin D3 concentrations, C-reactive protein levels, and coronary artery atherosclerosis in postmenopausal monkeys |
Q45217138 | The prevalence and characteristics of coronary atherosclerosis in asymptomatic subjects classified as low risk based on traditional risk stratification algorithm: assessment with coronary CT angiography |
Q34113174 | The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. |
Q33989516 | The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology |
Q36480698 | Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art. |
Q38092767 | Vascular calcification in diabetes: mechanisms and implications |
Q36305112 | Women and coronary artery disease. Part I: basic considerations. |
Q37462134 | Women and ischemic heart disease: evolving knowledge. |
Search more.